• Ahn ER, Lander G, Bidot CJ, Jy W, Ahn YS 2005 Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy. Am. J. Hematol. 78: 127-129. *

• Araki Y, Sakaguchi C, Ishizuka I, Sasaki M, Tsujikawa T, Koyama S, Furukawa A, Fujiyama Y 2005 Budd-Chiari syndrome: a case with a combination of hepatic vein and superior vena cava occlusion. World J. Gastroenterol. 11: 3797-3799. *

• Asherson RA, Cervera R 2003 Unusual manifestations of the antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 25: 61-78.

• Asimuakopoulos G 2006 Pregnancy and liver disease. Rev. Med. Chir. Soc. Med. Nat. Iasi. 110: 326-333.

• Attwell A, Ludkowski M, Nash R, Kugelmas M 2004 Treatment of Budd-Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment. Pharmacol. Ther. 20: 867-873. *

• Aydinli M, Bayraktar Y 2007 Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. World J. Gastroenterol. 13: 2693-2696. *

• Aydogdu S, Ozgenc F, Yurtsever S, Akman SA, Tokat Y, Yagci RV 2003 Our experience with fulminant hepatic failure in Turkish children: etiology and outcome. J. Trop. Pediatr. 49: 367-370. *

• Bachet JB, Condat B, Hagege H, Plessier A, Consigny Y, Belghiti J, Valla D 2007 Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. J. Hepatol. 46: 60-68. *

• Bachmann R, Strunk H, Brensing KA, Hofer U, Schild H 1998 Diagnosis and therapy of Budd-Chiari syndrome. Aktuelle. Radiol. 8: 213-219.

• Bajaj JS, Franco J 2008 Endoscopic band ligation of esophageal varices in patients on anticoagulation. J. Clin. Gastroenterol. 42: 782-785.

• Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M 1997 Budd-Chiari syndrome: a common complication of Behcet's disease. Am. J. Gastroenterol. 92: 858-862.

• Beppu T, Maruyama T, Ohashi K, Ohura S, Nakanishi R, Fukasawa M, Futagawa S 1992 Results of non-decompression surgery for esophago-gastric varices - postoperative disappearance, recurrence, rebleeding rate of varices, and cumulative survival rate. Nippon Geka Gakkai Zasshi 93: 1159-1163.

• Bernuau J 2003 Hepatic complications of pregnancy. Rev. Prat. 53: 1889-1893.

• Blendis L 2006 Budd-Chiari syndrome: a clinical model of the hepatorenal reflex? Gastroenterology 131: 671-672. *

• Blich M, Edoute Y 2004 Clinical manifestations of sarcoid liver disease. J. Gastroenterol. Hepatol. 19: 732-737. *

• Borchert DH 2008 Cavoportal hemitransposition for the simultaneous thrombosis of the caval and portal systems - a review of the literature. Ann. Hepatol. 7: 200-211. *

• Braham A, Safer L, Bdioui F, Lejmi A, Brahmi I, Ben Chabenne N, Ben Mimoun H, Saffar H 2001 Antiphospholipid antibodies in digestive diseases. Presse Med. 30: 1890-1897.

• Brancaccio V, Iannaccone L, Margaglione M, Guardascione MA, Amitrano L 2002 Multiple thrombophilic factors in a patient with Budd-Chiari syndrome. Clin. Lab. Haematol. 24: 61-63. *

• Brinson RR, Curtis WD, Schuman BM, Mills LR 1988 Recovery from hepatic vein thrombosis (Budd-Chiari syndrome) complicating ulcerative colitis. Dig. Dis. Sci. 33: 1615-1620.

• Brunerova L, Bartakova H, Jankovska M, Cieslarova B, Hulek P, Kozak T, Andel M 2004 The Budd-Chiari syndrome in a patient with primary thrombocythemia treated with interferon alfa and transjugular portosystemic shunt. Cas. Lek. Cesk. 143: 198-201.

• Burroughs AK, Patch D 1999 Transjugular intrahepatic portosystemic shunt. Semin. Liver Dis. 19: 457-473.

• Cappell MS 2008 Hepatic disorders severely affected by pregnancy: medical and obstetric management. Med. Clin. North Am. 92: 739-760.

• Castellano G, Canga F, Solis-Herruzo JA, Colina F, Martinez-Montiel MP, Morillas JD 1989 Budd-Chiari syndrome associated with nodular regenerative hyperplasia of the liver. J. Clin. Gastroenterol. 11: 698-702.

• Chesner IM, Muller S, Newman J 1986 Ulcerative colitis complicated by Budd-Chiari syndrome. Gut 27: 1096-1100. *

• Chuang FR, Lin CC, Wang PH, Cheng YF, Hsu KT, Chen YS, Lee CH, Chen CL 2004 Acute renal failure after cadaveric related liver transplantation. Transplant. Proc. 36: 2328-2330. *

• Delarive J, Gonvers JJ 1998 Budd-Chiari syndrome related to factor V Leiden mutation. Am. J. Gastroenterol. 93: 651-652. *

• Delay D, Lardi C, Jaussi A, von Segesser LK 2005 Hepato-atrial anastomosis, the "other Senning operation" for treatment of Budd-Chiari syndrome. Swiss Med. Wkly 135: 235-237. *

• DeLeve LD 2003 Vascular liver diseases. Curr. Gastroenterol. Rep. 5: 63-70.

• Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Briere J, Erlinger S, Valla DC 2001 Factor V Leiden related Budd-Chiari syndrome. Gut 48: 264-268. *

• Demetris AJ, Lasky S, Van Thiel DH, Starzl TE, Dekker A 1985 Pathology of hepatic transplantation: a review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am. J. Pathol. 118: 151-161.

• Deniz K, Ward SC, Rosen A, Grewal P, Xu R 2008 Budd-Chiari syndrome in sarcoidosis involving liver. Liver Int. 28: 580-581. *

• Disney TF, Sullivan SN, Haddad RG, Lowe D, Goldbach MM 1984 Budd-Chiari syndrome with inferior vena cava obstruction associated with systemic lupus erythematosus. J. Clin. Gastroenterol. 6: 253-256.

• Dolle W 1982 Liver damage caused by drugs. Dtsch. Z. Verdau. Stoffwechselkr. 42: 237-244.

• Elphick DA, Dube AK, McFarlane E, Jones J, Gleeson D 2007 Spectrum of liver histology in presumed decompensated alcoholic liver disease. Am. J. Gastroenterol. 102: 780-788. *

• Ernst L, Grossman A, Ruchelli E 2008 Familial perinatal liver disease and fetal thrombotic vasculopathy. Pediatr. Dev. Pathol. 11: 160-163.

• Faust TW 1999 Budd-Chiari syndrome. Curr. Treat. Options Gastroenterol. 2: 491-504.

• Fiedler A, Wichers-Rother M, Hoeft A, Putensen C, von Spiegel T, Schroeder S 2005 Schmidt syndrome presenting as acute liver failure. Exp. Clin. Endocrinol. Diabetes 113: 60-63.

• Friedewald SM, Molmenti EP, DeJong MR, Hamper UM 2003 Vascular and nonvascular complications of liver transplants: sonographic evaluation and correlation with other imaging modalities and findings at surgery and pathology. Ultrasound Q. 19: 71-85.

• Geller SA, Dubinsky MC, Poordad FF, Vasiliauskas EA, Cohen AH, Abreu MT, Tran T, Martin P, Vierling JM, Targan SR 2004 Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease. Am. J. Surg. Pathol. 28: 1204-1211.

• Gelsi E, Ruitord F, Saint-Paul MC, Filippi J, Arab K, Hebuterne X 2004 Association of Budd-Chiari syndrome with a coeliac disease in patient native from North Africa. Gastroenterol. Clin. Biol. 28: 903-905.

• Girlanda R, Rela M, Williams R, O'grady JG, Heaton ND 2005 Long-term outcome of immunosuppression withdrawal after liver transplantation. Transplant. Proc. 37: 1708-1709. *

• Grimaud JC, Bourliere M 1989 Contraception and hepatogastroenterology. Fertil. Contracept. Sex 17: 407-413.

• Han SW, Kim GW, Lee J, Kim YJ, Kang YM 2005 Successful treatment with stent angioplasty for Budd-Chiari syndrome in Behcet's disease. Rheumatol. Int. 25: 234-237. *

• Hernandez-Guerra M, Lopez E, Bellot P, Piera C, Turnes J, Abraldes JG, Bosch J, Garcia-Pagan JC 2006 Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome. Hepatology 43: 27-33. *

• Hernandez-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, Garcia-Pagan JC 2004 PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 40: 1197-1202. *

• Hoffman R, Nimer A, Lanir N, Brenner B, Baruch Y 1999 Budd-Chiari syndrome associated with factor V leiden mutation: a report of 6 patients. Liver Transpl. Surg. 5: 96-100.

• Horton JD, San Miguel FL, Ortiz JA 2008 Budd-Chiari syndrome: illustrated review of current management. Liver Int. 28: 455-466. *

• Hotoleanu C, Porojan-Iuga M, Rusu ML, Andercou A 2007 Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis. Rom. J. Intern. Med. 45: 159-164.

• Humar A 2004 Living donor liver transplants: potential disadvantages. J. Gastroenterol. Hepatol. 19: S304-S306. *

• Ibarrola C, Castellano VM, Colina F 2004 Focal hyperplastic hepatocellular nodules in hepatic venous outflow obstruction: a clinicopathological study of four patients and 24 nodules. Histopathology 44: 172-179. *

• Ilan Y, Oren R, Tur-Kaspa R 1993 Elevated growth hormone levels in patients with non-alcoholic chronic liver disease. J. Gastroenterol. Hepatol. 8: 448-450.

• Ilkgul O, Icoz G, Dayangac M, Tokat Y, Ozutemiz O 2004 A case of antiphospholipid antibody syndrome with Budd-Chiari and colonic ulcers complicated with gastrointestinal hemorrhage. Turk. J. Gastroenterol. 15: 115-116. *

• Ishak KG 1998 Sarcoidosis of the liver and bile ducts. Mayo Clin. Proc. 73: 467-472.

• Ishikawa A, Nishida H, Baba T, Mitamura K 2000 Evaluation of balloon-occluded hepatic venography with carbon dioxide for portography and correlation between retrograde portogram and liver function in patients with liver cirrhosis. Hepatol. Res. 18: 239-251.

• Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC; European Group for the Study of Vascular Disorders of the Liver 2003 Budd-Chiari syndrome: a review by an expert panel. J. Hepatol. 38: 364-371. *

• Junge U, Wienke J, Schuler A 2001 Acute Budd-Chiari syndrome, portal and splenic vein thrombosis in a patient with ulcerative colitis associated with antiphospholipid antibodies and protein C deficiency. Z. Gastroenterol. 39: 845-852.

• Kakar S, Batts KP, Poterucha JJ, Burgart LJ 2004 Histologic changes mimicking biliary disease in liver biopsies with venous outflow impairment. Mod. Pathol. 17: 874-878. *

• Khubchandani RP, D'Souza S 2003 Antiphospholipid antibody syndrome as a cause of Budd-Chiari syndrome. Indian Pediatr. 40: 907-908.

• Kirby DF, Blei AT, Rosen ST, Vogelzang RL, Neiman HL 1986 Primary sclerosing cholangitis in the presence of a lupus anticoagulant. Am. J. Med. 81: 1077-1080.

• Korkmaz C, Kasifoglu T, Kebapci M 2007 Budd-Chiari syndrome in the course of Behcet's disease: clinical and laboratory analysis of four cases. Joint Bone Spine 74: 245-248.

• Krastev N, Grigorov N, Dinkov L, Genov Y, Mitova R, Donov M 1998 The role of laparoscopy and laparoscopic ultrasonography in the diagnosis and differential diagnosis of nodular hepatocellular lesions. Khirurgiia (Sofiia) 53: 14-18.

• Le Bail B, Bioulac-Sage P, Senuita R, Quinton A, Saric J, Balabaud C 1990 Fine structure of hepatic sinusoids and sinusoidal cells in disease. J. Electron Microsc. Tech. 14: 257-282.

• Lefkowitch JH 2004 Hepatobiliary pathology. Curr. Opin. Gastroenterol. 20: 188-197.

• Liew CT 1990 A comparative histopathological study of hepatic venous outflow obstruction in veno-occlusive disease and Budd-Chiari's syndrome. Changgeng Yi Xue Za Zhi 13: 167-181.

• Lopez-Mendez E, Chavez-Tapia NC, Avila-Escobedo L, Cabrera-Aleksandrova T, Uribe M 2006 Early experience of Budd-Chiari syndrome treatment with transjugular intrahepatic portosystemic shunt. Ann. Hepatol. 5: 157-160. *

• Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, Lake JR, Martin P, McDiarmid SV, Rakela J, Shiffman ML, So SK, Wiesner RH 1997 Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl. Surg. 3: 628-637.

• Maccini DM, Berg JC, Bell GA 1989 Budd-Chiari syndrome and Crohn's disease. An unreported association. Dig. Dis. Sci. 34: 1933-1936.

• Manzano ML, Garfia C, Manzanares J, Urruzuno P, Yela C, Castellano G, Solis JA 2002 Celiac disease and Bud-Chiari syndrome: an uncommon association. Gastroenterol. Hepatol. 25: 159-161.

• Matsui O 2004 Portal hypertension and Budd-Chiari syndrome: intervention. J. Gastroenterol. Hepatol. 19: S406-S409. *

• McIntyre N 2002 Sheila: Professor Dame Sheila Sherlock (1918-2001). Hepatology 35: 507-509. *

• Mendez-Sanchez N, Chavez-Tapia NC, Lopez-Mendez E, Uribe M 2005 Budd-Chiari syndrome. Ann. Hepatol. 4: 204. *

• Menon KV, Shah V, Kamath PS 2004 The Budd-Chiari syndrome. N. Engl. J. Med. 350: 578-585. *

• Mete N, Yilmaz F, Gulbahar O, Aydin A, Sin A, Kokuludag A, Yuce G, Sebik F 2003 Allopurinol hypersensitivity syndrome as a cause of hepatic centrilobular hemorrhagic necrosis. J. Investig. Allergol. Clin. Immunol. 13: 281-283.

• Mieli-Vergani G, Vergani D 2004 Approach to a child with chronic liver disease. J. Gastroenterol. Hepatol. 19: S377-S378. *

• Millonig G, Stadlmann S, Vogel W 2005 Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur. J. Gastroenterol. Hepatol. 17: 445-447.

• Murad SD, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, Janssen HL 2006 Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am. J. Gastroenterol. 101: 83-90. *

• Nyckowski P, Dudek K, Skwarek A, Zieniewicz K, Pawlak J, Patkowski W, Michalowicz B, Alsharabi A, Wroblewski T, Leowska E, Paczkowska A, Oldakowska-Jedynak U, Paczek L, Krawczyk M 2003 Results of liver transplantation according to indications for orthotopic liver transplantation. Transplant. Proc. 35: 2265-2267. *

• Okuda K 2002 Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin. Liver Dis. 22: 15-26.

• Orug T, Soonawalla ZF, Tekin K, Olliff SP, Buckels JA, Mayer AD 2004 Role of surgical portosystemic shunts in the era of interventional radiology and liver transplantation. Br. J. Surg. 91: 769-773. *

• Ouakaa-Kchaou A, Ennaifer R, Belhadj N, Gargouri D, Elloumi H, Romani M, Kochlef A, Kilani A, Kharrat J, Ghorbel A 2008 Celiac disease associated with Budd-Chiari syndrome. Presse. Med. 37: 239-241.

• Paradis V, Bieche I, Dargere D, Cazals-Hatem D, Laurendeau I, Saada V, Belghiti J, Bezeaud A, Vidaud M, Bedossa P, Valla DC 2005 Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease. Gut 54: 1776-1781. *

• Park SY, Kim YJ, Park IH, Moon CM, Choi CW, Lee SK, Kim H, Park YN, Kim TI, Kim WH 2005 A case of Budd-Chiari syndrome and superior mesenteric vein thrombosis in ulcerative colitis. Korean J. Gastroenterol. 45: 201-205.

• Pelletier S, Landi B, Piette JC, Ekert P, Coutellier A, Desmoulins C, Fadlallah JP, Herson S, Valla D 1994 Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J. Hepatol. 21: 76-80.

• Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, Farges O, Chagneau C, de Ledinghen V, Francoz C, Sauvanet A, Vilgrain V, Belghiti J, Durand F, Valla D 2006 Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 44: 1308-1316. *

• Praderio L, Dagna L, Longhi P, Rubin G, Sabbadini MG 2000 Budd-Chiari syndrome in a patient with ulcerative colitis: association with anticardiolipin antibodies. J. Clin. Gastroenterol. 30: 203-204.

• Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, Dell'era A, Bucciarelli P, Mannucci PM 2006 Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 44: 1528-1534. *

• Rahhal RM, Pashankar DS, Bishop WP 2005 Ulcerative colitis complicated by ischemic colitis and Budd Chiari syndrome. J. Pediatr. Gastroenterol. Nutr. 40: 94-97. *

• Rais-Jalali GA, Sagheb MM, Daniali F, Behzadi S, Roozbeh J, Nikeghbalian S, Bahador A, Salahi H, Malek-Hosseini SA 2007 Acute renal failure in the first 100 orthotopic liver transplant patients in southern Iran. Exp. Clin. Transplant. 5: 710-712.

• Rav-Acha M, Gur C, Ilan Y, Verstandig A, Eid A 2004 Budd-Chiari syndrome: updated treatment modalities. Harefuah. 143: 372-376, 389.

• Renz JF, Ascher NL 2002 Liver transplantation for nonviral, nonmalignant diseases: problem of recurrence. World J. Surg. 26: 247-256. *

• Robles-Medranda C, Lukashok H, Biccas B, Pannain VL, Fogaca HS 2006 Budd-Chiari like syndrome in decompensated alcoholic steatohepatitis and liver cirrhosis. World J. Gastroenterol. 12: 6564-6566. *

• Romero-Gomez M, Ramirez-Martin-Del Campo M, Merchante N, Escalada-Berta J 2004 Transient Budd-Chiari syndrome due to iatrogenic subcapsular fluid accumulation following thoracocentesis. Am. J. Gastroenterol. 99: 2281-2282. *

• Ruh J, Malago M, Busch Y, Lang H, Paul A, Verhagen R, Broelsch CE 2005 Management of Budd-Chiari syndrome. Dig. Dis. Sci. 50: 540-546. *

• Ryu RK, Durham JD, Krysl J, Shrestha R, Shrestha R, Everson GT, Stephens J, Kam I, Wachs M, Kumpe DA 1999 Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. J. Vasc. Interv. Radiol. 10: 799-805.

• Sakata H, Sugawara Y, Makuuchi M 2007 Hepatobiliary and pancreatic: acute Budd-Chiari syndrome treated by systemic thrombolytic therapy. J. Gastroenterol. Hepatol. 22: 444. *

• Schiedermaier P 2004 Splanchnic hemodynamics: cirrhotic versus non-cirrhotic portal hypertension. J. Gastroenterol. Hepatol. 19: S150-S154. *

• Schmidt R, Scheuermann EH, Viertel A, Geiger H, Scharrer I 1999 Antiphospholipid antibody syndrome. Med. Klin. (Munich) 94: 93-100.

• Schweizer W, Schott G, Zimmermann A, Triller J, Blumgart LH 1993 Clinical significance and histological classification of atrophy/hypertrophy complexes of the liver. Schweiz. Med. Wochenschr. 123: 1598-1603.

• Selvaggi G, Weppler D, Nishida S, Moon J, Levi D, Kato T, Tzakis AG 2007 Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis. Am. J. Transplant. 7: 454-460. *

• Senzolo M, Cholongitas EC, Patch D, Burroughs AK 2005 Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 182-190. *

• Sethy PK, Dutta U, Aggrawal AN, Das R, Gulati M, Sinha SK, Singh K 2003 Pulmonary and hematological alterations in idiopathic ulcerative colitis. Indian J. Gastroenterol. 22: 176-179.

• Shrestha R, Durham JD, Wachs M, Bilir BM, Kam I, Trouillot T, Everson GT 1997 Use of transjugular intrahepatic portosystemic shunt as a bridge to transplantation in fulminant hepatic failure due to Budd-Chiari syndrome. Am. J. Gastroenterol. 92: 2304-2306.

• Srinivasan P, Rela M, Prachalias A, Muiesan P, Portmann B, Mufti GJ, Pagliuca A, O'Grady J, Heaton N 2002 Liver transplantation for Budd-Chiari syndrome. Transplantation 73: 973-977.

• Sugano S, Suzuki T, Makino H, Yanagimoto S, Nishio M, Onmura H, Iinuma M, Matuda T, Shinozawa Y 1996 Budd-Chiari syndrome attributed to protein C deficiency. Am. J. Gastroenterol. 91: 777-779.

• Summerfield JA 2001 Liver failure. ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net. *

• Tabatabai L, Lewis WD, Gordon F, Jenkins R, Khettry U 1999 Fibrosis/cirrhosis after orthotopic liver transplantation. Hum. Pathol. 30: 39-47.

• Thomas M, Caroli J 1971 Polycythemia and Budd-Chiari syndrome. Apropos of 17 cases. Ann. Med. Interne (Paris) 122: 1175-1186.

• Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B 2008 Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J. Gastroenterol. 14: 2858-2862. *

• Uthman I, Khamashta M 2007 The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford) 46: 1641-1647.

• Valla DC 2008 Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome. Gut 57: 1469-1478.

• Valla DC 2002 Hepatic vein thrombosis (Budd-Chiari syndrome). Semin. Liver Dis. 22: 5-14.

• van der Putten AB, Bijleveld CM, Slooff MJ, Wesenhagen H, Gips CH 1987 Selection criteria and decisions in 375 patients with liver disease, considered for liver transplantation during 1977-1985. Liver 7: 84-90.

• van Hoek B 1996 The spectrum of liver disease in systemic lupus erythematosus. Neth. J. Med. 48: 244-253.

• Vilgrain V, Lewin M, Vons C, Denys A, Valla D, Flejou JF, Belghiti J, Menu Y 1999 Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 210: 443-450. *

• Wang ZG, Zhang FJ, Li QX, Meng QY 2004 Management of Budd-Chiari syndrome: what is the best approach? J. Gastroenterol. Hepatol. 19: S212-S218. *

• Wanless IR 2004 The pathogenesis of focal nodular hyperplasia of the liver. J. Gastroenterol. Hepatol. 19: S342-S343. *

• Wei G, Kalaitzakis E, Bergquist A, Bjornsson E 2008 Long-term follow-up of patients with acute liver failure of indeterminate aetiology. Scand. J. Gastroenterol. Mar 13 [Epub ahead of print]. *

• Whelan G, Peters M, Desmond PV, Bhathal PS 1982 Alcohol unrelated hepato-biliary disorders in the alcoholic: the role of liver biopsy in determining the aetiology of liver disease. Aust. N. Z. J. Med. 12: 34-38.

• Whiteford MH, Moritz MJ, Ferber A, Fry RD 1999 Budd-Chiari syndrome complicating restorative proctocolectomy for ulcerative colitis: report of a case. Dis. Colon Rectum 42: 1220-1224.

• Williams R 2005 Clinical management of acute liver failure. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 82. *

• Witteman BJ, Weterman IT, Griffioen G, Lamers CB 1991 Intestinal obstruction caused by non-absorbable tablets and Budd-Chiari syndrome in a patient with Crohn's disease. Ned. Tijdschr. Geneeskd. 135: 766-769.

• Wong F 2006 The use of TIPS in chronic liver disease. Ann. Hepatol. 5: 5-15. *

• Youssef WI, Tavill AS 2002 Connective tissue diseases and the liver. J. Clin. Gastroenterol. 35: 345-349.

• Yuce B, Gulberg V, Diebold J, Gerbes AL 2006 Hepatitis induced by noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg? Digestion 73: 167-170.

Number of references = 124

www psc-literature.org